The general recommendation for people on GLP-1 medications is 2 to 3 liters per day, which translates to roughly 67-100 ounces
14 However, in two studies that included participants not enrolled in the SURPASS and SURMOUNT studies, ie, a large number of individuals who switched from other GLP-1 RAs to tirzepatide, those who transitioned from semaglutide experienced greater weight loss with tirzepatide treatment
Ideal candidates include adults interested in evidence-based longevity interventions, individuals seeking to optimize healthspan and biological age, patients with family histories of age-related disease, and those committed to comprehensive preventive health strategies
Peptide studies examining fragment-based lipolytic compounds have often focused on subcutaneous tissue specifically, given its more localized and measurable response pattern compared to visceral fats organ-adjacent positioning
You and your doctor should carefully weigh the benefits of oral GLP-1 medications against the potential risks